Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
Recruiting
N/A
Interventional Study
Knee Osteoarthritis (Knee OA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 72 (estimated)
- Sponsor
- Next Biomedical Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study in patients with knee osteoarthritis treated by embolization using NBGM200
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Osteoarthritis proven by MR-imaging
Exclusion Criteria:
* Current local infection
* Life expectancy less than 6 months
Contacts
No contact information available.